KALV: KalVista Pharmaceuticals Inc

14.05 USD 0.23 (1.66%)

Setor: Cuidados de saúde Base: US Dollar Moeda de lucro: US Dollar

A taxa do KALV para hoje mudou para 1.66%. Paralelamente, o preço mais baixo no mercado atingiu 13.68 e o mais alto foi 14.34.

Veja a dinâmica do par de moedas KalVista Pharmaceuticals Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.

Tela cheia

KALV Notícias

Seeking Alpha 09:02 KalVista's EKTERLY Faces Shrinking Market, Oral Competitor Threat (Downgrade) (KALV)
Investing 12:32 European regulator recommends approval of first oral HAE treatment
Investing 08:59 Kalvista Pharmaceuticals stock maintains Market Outperform rating at JMP
Investing 09:05 JMP reiterates Market Outperform rating on Kalvista stock after UK approval
Investing 20:12 UK approves first oral treatment for hereditary angioedema attacks
Seeking Alpha 19:24 Astria: Betting On Navenibart In The Crowded HAE Arena
Benzinga 12:14 Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Apple (NASDAQ:AAPL), Above Food Ingredients (NASDAQ:ABVE)
Investing 11:25 Kalvista stock maintains Buy rating at H.C. Wainwright on favorable Ekterly label
Investing 01:01 Kalvista Pharma CEO Palleiko sells $517k in shares
Investing 00:52 Kalvista Pharma chief development officer sells $474k in shares
Investing 15:15 Leerink Partners reiterates Outperform rating on Kalvista stock as Ekterly launch begins
Seeking Alpha 19:52 KalVista: FDA Approval Of EKTERLY As Oral On-Demand HAE Drug Is Just Beginning (KALV)
Benzinga 14:03 Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday - Abbott Laboratories (NYSE:ABT), Danaher (NYSE:DHR)
Investing 08:53 Kalvista stock price target raised to $27 from $19 at JMP on Ekterly pricing
Investing 19:27 Kalvista stock rises as Leerink raises price target on FDA approval
Investing 18:01 Tesla, Circle Internet Surge Among Monday’s Market Cap Stock Movers
Investing 17:11 KalVista stock price target raised to $37 from $22 at BofA on Ekterly approval
Investing 14:36 Kalvista stock jumps as Stifel reiterates Buy rating on Ekterly approval
Investing 14:31 Tesla, Oracle among Monday’s market cap stock movers
Benzinga 14:05 KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday - Amber International (NASDAQ:AMBR), Baidu (NASDAQ:BIDU)
Investor's Business Daily 13:12 KalVista Ends Its Unexpectedly Messy Path To Approval In HAE Treatment
Investing 12:22 US FDA approves KalVista Pharma’s swelling disorder drug, shares rise
Benzinga 11:47 Why Is KalVista Pharmaceuticals Stock Soaring On Monday? - KalVista Pharma (NASDAQ:KALV)
Investing 11:26 KalVista stock soars after FDA approves first oral HAE treatment

Faixa diária

13.68 14.34

Faixa anual

7.31 16.32

Fechamento anterior: 13.75
Open: 13.82

Bid: 14.05
Ask: 14.35

Low: 13.68
High: 14.34

Volume: 1.843 K

Mudança diária: 1.66%
Mudança mensal: 24.89%

Mudança de 6 meses: 60.39%
Mudança anual: -5.32%

30 julho, quarta-feira